Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

In Vivo Dosimetry for Single-Fraction Targeted Intraoperative Radiotherapy (TARGIT) for Breast Cancer

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1];  [2];  [1];  [3];  [1]; ;  [3];  [2];  [4]
  1. Department of Radiotherapy Physics, Royal Free Hospital, University College London, London (United Kingdom)
  2. Research Department of Surgery, Division of Surgery and Interventional Science, University College London, London (United Kingdom)
  3. Department of Radiotherapy, Royal Free Hospital, University College London, London (United Kingdom)
  4. Department of Surgery, Royal Free Hospital, University College London, London (United Kingdom)
Purpose: In vivo dosimetry provides an independent check of delivered dose and gives confidence in the introduction or consistency of radiotherapy techniques. Single-fraction intraoperative radiotherapy of the breast can be performed with the Intrabeam compact, mobile 50 kV x-ray source (Carl Zeiss Surgical, Oberkochen, Germany). Thermoluminescent dosimeters (TLDs) can be used to estimate skin doses during these treatments. Methods and Materials: Measurements of skin doses were taken using TLDs for 72 patients over 3 years of clinical treatments. Phantom studies were also undertaken to assess the uncertainties resulting from changes in beam quality and backscatter conditions in vivo. Results: The mean measured skin dose was 2.9 {+-} 1.6 Gy, with 11% of readings higher than the prescription dose of 6 Gy, but none of these patients showed increased complications. Uncertainties due to beam hardening and backscatter reduction were small compared with overall accuracy. Conclusions: TLDs are a useful and effective method to measure in vivo skin doses in intraoperative radiotherapy and are recommended for the initial validation or any modification to the delivery of this technique. They are also an effective tool to show consistent and safe delivery on a more frequent basis or to determine doses to other critical structures as required.
OSTI ID:
22056287
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 5 Vol. 82; ISSN IOBPD3; ISSN 0360-3016
Country of Publication:
United States
Language:
English